With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

Scientists have engineered a highly selective catalyst that can convert methane, a major component of natural gas, into methanol, an easily transportable liquid fuel, in a single, one-step reaction.

State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more I've spent more than a decade reviewing audio gear, and year after year, Sony's wireless headphones earn ...

Studios embrace AI: Naughty Dog and other PlayStation teams are using AI tools like Mockingbird to speed up facial animation and hair modeling. Efficiency without replacement: Sony stresses AI will ...

Sony is a leading name in mirrorless photography, favored by both content creators and photography enthusiasts alike. These are the top Sony cameras we've tested. Images, and the devices that capture ...

Sony earbuds have a pedigree, with numerous pairs earning five-star ratings and What Hi-Fi? Awards accolades over the years. Which is why it makes perfect sense that you may be considering a pair with ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...